COG-301

N/A

Report date: 2025/08/01 13:19:40

Base Information

Drug NameCOG-301

Drug Alias NameCOG-301

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNACell and gene therapy > Gene therapy > LNP

Mechanisms of ActionSerotonin 2a (5-HT2a) receptor inhibitors

TargetsSerotonin 2a (5-HT2a) receptor

Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCognigenics Inc

China Registration ClassN/A

Develop Information

Active CompaniesCognigenics Inc

Inactive CompaniesN/A

Active IndicationsAttention Deficit Disorder with HyperactivityParkinson Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A